Trial intelligence / Profile preview

Clobetasol cream versus calcipotriol + betamethasone dipropionate foam in plaque psoriasis

2017-004451-24Phase 4Active

Sponsor
Fundació Clínic per a la Recerca Biomèdica
Start
Nov 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in plaque psoriasis comparing Clobetasol cream with Calcipotriol + betamethasone dipropionate foam (2 arms). Primary endpoint: Clinical response and microscopic changes in plaque psoriasis identifiers. Started Nov 2017; status: active.

02

Drugs

clobetasolcalcipotriolbetamethasone dipropionate
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on 2017-004451-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-004451-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call